The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients.


Journal

Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 21 07 2022
accepted: 16 01 2023
revised: 26 10 2022
medline: 14 7 2023
pubmed: 8 2 2023
entrez: 7 2 2023
Statut: ppublish

Résumé

Atopic dermatitis (AD) is a common inflammatory chronic skin disease typically associated with atopic comorbidities and other non-atopic conditions such as sleep disturbances, and mood/anxiety disorders. A growing literature proposed a crucial role of sleep disturbances in the development of mental health problems in AD. We tested this assumption by mediation model analyses in adult AD patients.A total of 57 patients (mean age ± std. dev., 34.28 ± 13.07 years; 27 males; range 18-67 years) diagnosed with AD participated in a cross-sectional study. We evaluated self-perceived severity of AD, insomnia, depression, and anxiety symptoms using validated questionnaires: the Patient-Oriented Eczema Measure (POEM), the Insomnia Severity Index (ISI), the Beck Depression Inventory-second edition (BDI-II), and the Generalized Anxiety Disorder-7 scale (GAD-7), respectively. Two mediation models were performed, testing the mediation effect of insomnia symptoms on the relationship between AD severity and depression (model 1) and anxiety (model 2). AD symptoms, as expressed by POEM, were positively associated with insomnia, depression, and anxiety severity. Insomnia fully mediated the effect of AD severity on depression and anxiety. Specifically, insomnia accounted for 81.64% of the relationship between atopic eczema severity and depression, and for 81.84% of the effect of AD severity on anxiety symptoms. The present study proposed a critical role of insomnia in predisposing adult AD patients to experience depression and anxiety. Early interventions focused on treating sleep disturbances could indirectly be beneficial on mental health of patients with AD, counteracting the onset and exacerbation of anxiety and depression disorders.

Identifiants

pubmed: 36749389
doi: 10.1007/s00403-023-02538-0
pii: 10.1007/s00403-023-02538-0
pmc: PMC10338550
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1577-1582

Informations de copyright

© 2023. The Author(s).

Références

Bieber T (2008) Atopic dermatitis. N Engl J Med 358:1483–1494. https://doi.org/10.1056/NEJMRA074081
doi: 10.1056/NEJMRA074081 pubmed: 18385500
Sen CY, Chiang BL (2018) Sleep disorders and atopic dermatitis: a 2-way street? J Allergy Clin Immunol 142:1033–1040. https://doi.org/10.1016/J.JACI.2018.08.005
doi: 10.1016/J.JACI.2018.08.005
Jeon C, Yan D, Nakamura M et al (2017) Frequency and management of sleep disturbance in adults with atopic dermatitis: a systematic review. Dermatol Ther 7:349–364. https://doi.org/10.1007/S13555-017-0192-3
doi: 10.1007/S13555-017-0192-3
Yano C, Saeki H, Ishiji T et al (2013) Impact of disease severity on sleep quality in Japanese patients with atopic dermatitis. J Dermatol Sci 72:195–197. https://doi.org/10.1016/J.JDERMSCI.2013.06.010
doi: 10.1016/J.JDERMSCI.2013.06.010 pubmed: 23876306
Sánchez-Pérez J, Daudén-Tello E, Mora AM, Lara Surinyac N (2013) Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: the PSEDA study. Actas Dermosifiliogr 104:44–52. https://doi.org/10.1016/J.AD.2012.03.008
doi: 10.1016/J.AD.2012.03.008 pubmed: 22841507
Bender BG, Ballard R, Canono B et al (2008) Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol 58:415–420. https://doi.org/10.1016/J.JAAD.2007.10.010
doi: 10.1016/J.JAAD.2007.10.010 pubmed: 18280338
Sandoval LF, Huang K, O’Neill JL et al (2014) Measure of atopic dermatitis disease severity using actigraphy. J Cutan Med Surg 18:49–55. https://doi.org/10.2310/7750.2013.13093
doi: 10.2310/7750.2013.13093 pubmed: 24377474
Silverberg JI (2017) Selected comorbidities of atopic dermatitis: atopy, neuropsychiatric, and musculoskeletal disorders. Clin Dermatol 35:360–366. https://doi.org/10.1016/j.clindermatol.2017.03.008
doi: 10.1016/j.clindermatol.2017.03.008 pubmed: 28709566 pmcid: 5512438
Silverberg JI, Garg NK, Paller AS et al (2015) Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol 135:56–66. https://doi.org/10.1038/jid.2014.325
doi: 10.1038/jid.2014.325 pubmed: 25078665
Beikert FC, Langenbruch AK, Radtke MA et al (2014) Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res 306:279–286. https://doi.org/10.1007/S00403-013-1402-1
doi: 10.1007/S00403-013-1402-1 pubmed: 23982630
Yu SH, Attarian H, Zee P, Silverberg JI (2016) Burden of sleep and fatigue in US adults with atopic dermatitis. Dermatitis 27:50–58. https://doi.org/10.1097/DER.0000000000000161
doi: 10.1097/DER.0000000000000161 pubmed: 26983091
Hertenstein E, Feige B, Gmeiner T et al (2019) Insomnia as a predictor of mental disorders: a systematic review and meta-analysis. Sleep Med Rev 43:96–105. https://doi.org/10.1016/j.smrv.2018.10.006
doi: 10.1016/j.smrv.2018.10.006 pubmed: 30537570
Baglioni C, Battagliese G, Feige B et al (2011) Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 135:10–19. https://doi.org/10.1016/J.JAD.2011.01.011
doi: 10.1016/J.JAD.2011.01.011 pubmed: 21300408
Buysse DJ, Angst J, Gamma A et al (2008) Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 31:473–480. https://doi.org/10.1093/sleep/31.4.473
doi: 10.1093/sleep/31.4.473 pubmed: 18457234 pmcid: 2279748
Neckelmann D, Mykletun A, Dahl AA (2007) Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 30:873. https://doi.org/10.1093/SLEEP/30.7.873
doi: 10.1093/SLEEP/30.7.873 pubmed: 17682658 pmcid: 1978360
Bao Q, Chen L, Lu Z et al (2018) Association between eczema and risk of depression: a systematic review and meta-analysis of 188,495 participants. J Affect Disord 238:458–464. https://doi.org/10.1016/J.JAD.2018.05.007
doi: 10.1016/J.JAD.2018.05.007 pubmed: 29929155
Patel KR, Immaneni S, Singam V et al (2019) Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis. J Am Acad Dermatol 80:402–410. https://doi.org/10.1016/J.JAAD.2018.08.063
doi: 10.1016/J.JAAD.2018.08.063 pubmed: 30365995
Schonmann Y, Mansfield KE, Hayes JF et al (2020) Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study. J Allergy Clin Immunol Pract 8:248-257.e16. https://doi.org/10.1016/J.JAIP.2019.08.030
doi: 10.1016/J.JAIP.2019.08.030 pubmed: 31479767 pmcid: 6947493
Silverberg JI, Gelfand JM, Margolis DJ et al (2019) Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol 181:554–565. https://doi.org/10.1111/BJD.17683
doi: 10.1111/BJD.17683 pubmed: 30838645 pmcid: 6850653
Baurecht H, Welker C, Baumeister S-E et al (2021) Relationship between atopic dermatitis, depression and anxiety: a two-sample Mendelian randomization study. Br J Dermatol 185:781–786. https://doi.org/10.1111/bjd.20092
doi: 10.1111/bjd.20092 pubmed: 33817779
Charman CR, Venn AJ, Williams HC et al (2004) The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol 140:1513–1519. https://doi.org/10.1001/ARCHDERM.140.12.1513
doi: 10.1001/ARCHDERM.140.12.1513 pubmed: 15611432
Castronovo V, Galbiati A, Marelli S et al (2016) Validation study of the Italian version of the Insomnia Severity Index (ISI). Neurol Sci 37:1517–1524. https://doi.org/10.1007/s10072-016-2620-z
doi: 10.1007/s10072-016-2620-z pubmed: 27234459
Ghisi M, Flebus G, Montano A et al (2006) Beck Depression Inventory-II: Edizione Italiana. Giunti Editore, Firenze
Spitzer RL, Kroenke K, Williams JBW, Löwe B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092–1097
doi: 10.1001/archinte.166.10.1092 pubmed: 16717171
Hayes AF (2017) Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. Methodology in the Social Sciences, 2nd edn. Guilford Publications Inc, New York
MacKinnon DP (2008) Introduction to statistical mediation analysis. Taylor & Francis Inc, Abingdon
Rønnstad ATM, Halling-Overgaard AS, Hamann CR, Skov L, Egeberg A, Thyssen JP (2018) Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis. J Am Acad Dermatol 79(3):448–456. https://doi.org/10.1016/j.jaad.2018.03.017
doi: 10.1016/j.jaad.2018.03.017 pubmed: 30119868
Silverberg JI, Chiesa-Fuxench Z, Margolis D et al (2021) Sleep disturbances in atopic dermatitis in US adults. Dermatitis. https://doi.org/10.1097/der.0000000000000731
doi: 10.1097/der.0000000000000731 pubmed: 34807542 pmcid: 10115559
Bawany F, Northcott CA, Beck LA, Pigeon WR (2021) Sleep disturbances and atopic dermatitis: relationships, methods for assessment, and therapies. J Allergy Clin Immunol Pract 9(4):1488–1500. https://doi.org/10.1016/j.jaip.2020.12.007
doi: 10.1016/j.jaip.2020.12.007 pubmed: 33321263
Alvaro PK, Roberts RM, Harris JK, Shao A (2013) A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep 36:1059–1068. https://doi.org/10.5665/sleep.2810
doi: 10.5665/sleep.2810 pubmed: 23814343 pmcid: 3669059

Auteurs

Federico Salfi (F)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Giulia Amicucci (G)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Department of Psychology, Sapienza University of Rome, Rome, Italy.

Michele Ferrara (M)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Daniela Tempesta (D)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Andrea De Berardinis (A)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
UOSD General and Oncologic Dermatology, San Salvatore Hospital, L'Aquila, Italy.

Andrea Chiricozzi (A)

UOC di DermatologiaDipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.
Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.

Ketty Peris (K)

UOC di DermatologiaDipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.
Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.

Maria Concetta Fargnoli (MC)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. mariaconcetta.fargnoli@univaq.it.
UOSD General and Oncologic Dermatology, San Salvatore Hospital, L'Aquila, Italy. mariaconcetta.fargnoli@univaq.it.

Maria Esposito (M)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
UOSD General and Oncologic Dermatology, San Salvatore Hospital, L'Aquila, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH